Correlation Between GM and BRIM Biotechnology

Can any of the company-specific risk be diversified away by investing in both GM and BRIM Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GM and BRIM Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between General Motors and BRIM Biotechnology, you can compare the effects of market volatilities on GM and BRIM Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short position of BRIM Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of GM and BRIM Biotechnology.

Diversification Opportunities for GM and BRIM Biotechnology

0.75

Correlation Coefficient

GM  BRIM Biotechnology

Poor diversification

The 3 months correlation between GM and BRIM is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding General Motors and BRIM Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BRIM Biotechnology and GM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Motors are associated (or correlated) with BRIM Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BRIM Biotechnology has no effect on the direction of GM i.e., GM and BRIM Biotechnology go up and down completely randomly.

Pair Corralation between GM and BRIM Biotechnology

Allowing for the 90-day total investment horizon General Motors is expected to generate 0.8 times more return on investment than BRIM Biotechnology. However, General Motors is 1.25 times less risky than BRIM Biotechnology. It trades about -0.07 of its potential returns per unit of risk. BRIM Biotechnology is currently generating about -0.19 per unit of risk. If you would invest  5,492  in General Motors on December 1, 2024 and sell it today you would lose (579.00) from holding General Motors or give up 10.54% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	78.33%
Values	Daily Returns

General Motors  vs.  BRIM Biotechnology

General Motors

Risk-Adjusted Performance

Very Weak

Over the last 90 days General Motors has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's primary indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

BRIM Biotechnology

Risk-Adjusted Performance

Very Weak

Over the last 90 days BRIM Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with GM and BRIM Biotechnology

The main advantage of trading using opposite GM and BRIM Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GM position performs unexpectedly, BRIM Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BRIM Biotechnology will offset losses from the drop in BRIM Biotechnology's long position.

The idea behind General Motors and BRIM Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.